Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(11/week)
India
(5/week)
Canada
(5/week)
Philippines
(1/week)
Korea, South
(1/week)
View all
(23/week)
News
United States
(1117/week)
Manufacturing
(564/week)
Technology
(1119/week)
Energy
(376/week)
Environment
(378/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
TNF inhibitor
Sep 12, 2018
Biosimilar Cyltezo® demonstrates clinical equivalence to Humira® in patients with moderate-to-severe plaque psoriasis
Sep 10, 2018
Lilly to Showcase New Data at the 27th European Academy of Dermatology and Venereology (EADV) Congress, Furthering Innovation for Patients with Complex Dermatological Conditions
Sep 04, 2018
AbbVie Reinforces Leadership in Dermatology With New Data Showcasing Research Advancements Across Growing Portfolio at the 27th European Academy of Dermatology and Venereology (EADV) Congress
Aug 13, 2018
Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis
Jun 28, 2018
Lilly Announces Positive Top-Line Results for Second Phase 3 Study of Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) for TNF Inhibitor-Experienced Patients
Jun 11, 2018
Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology
Jun 01, 2018
FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis
Apr 09, 2018
Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
Apr 02, 2018
Prestigious Paul Ehrlich Award Bestowed Upon Araim Pharmaceuticals Founder, Anthony Cerami
Mar 22, 2018
CIMZIA® (certolizumab pegol) label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.
Dec 01, 2017
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
Nov 21, 2017
Takeda's Entyvio Defends Share Against Janssen's Stelara in the Crohn's Disease Market, and Pressure in the Ulcerative Colitis Market May Heat Up in Early 2018 if Pfizer's Xeljanz Secures an FDA Win
Nov 06, 2017
UCB Presents New Findings Advancing Patient Care for Chronic Inflammatory Diseases and Osteoporosis at 2017 ACR/ARHP Annual Meeting
Nov 06, 2017
Efficacy and safety maintained in patients who switched from Humira® to biosimilar Cyltezo®
Oct 25, 2017
Nail psoriasis data now part of HUMIRA® label
Oct 24, 2017
AbbVie to Showcase Robust Immunology Portfolio with New and Late-Breaking Data at the 2017 ACR/ARHP Annual Meeting
Oct 24, 2017
DRG launches Patient Profiler, dramatically advancing the understanding of patient-level drivers in rheumatoid arthritis
Oct 20, 2017
Janssen Receives Two U.S. FDA Approvals For SIMPONI ARIA® (golimumab) For The Treatment Of Adults With Active Psoriatic Arthritis Or Active Ankylosing Spondylitis
Oct 17, 2017
Study Results of ACT-101 in a Model of Inflammatory Bowel Disease (IBD) Presented at the World Congress of Gastroenterology 2017
Aug 29, 2017
Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for Cyltezo(TM) (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases
‹‹
Page 3
››
Latest News
Jun 1, 2024
The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe...
Jun 1, 2024
Fonon's Additive Manufacturing Technology To Transform Construction Industry
Jun 1, 2024
Vapesol announces participation in exclusive New York workshop featuring B Kloud technology
Jun 1, 2024
US seeks to build Asia-Pacific version of NATO to maintain hegemony: China defence official
Jun 1, 2024
Austin praises 'new era of security' in Asia-Pacific
Jun 1, 2024
Austin says 'new era of security' in Asia-Pacific
Jun 1, 2024
Austin says US 'can be secure only if Asia is'
Jun 1, 2024
Pacific Coast Oil Trust Announces There Will Be No May Cash Distribution
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events